These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23768206)

  • 21. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.
    Chong J; Haran C; Chauhan BF; Asher I
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011032. PubMed ID: 26197430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarker-based asthma phenotypes of corticosteroid response.
    Cowan DC; Taylor DR; Peterson LE; Cowan JO; Palmay R; Williamson A; Hammel J; Erzurum SC; Hazen SL; Comhair SAA
    J Allergy Clin Immunol; 2015 Apr; 135(4):877-883.e1. PubMed ID: 25488689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma.
    Spallarossa D; Battistini E; Silvestri M; Sabatini F; Biraghi MG; Rossi GA
    J Asthma; 2001 Oct; 38(7):545-53. PubMed ID: 11714077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid phobia among parents of asthmatic children.
    Özçeker D; Uçkun U; İslamova D; Tamay Z; Güler N
    Turk J Pediatr; 2018; 60(2):142-146. PubMed ID: 30325119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between exhaled nitric oxide, rs28364072 polymorphism of FCER2 gene, asthma control, and inhaled corticosteroid responsiveness in children with asthma.
    Duong-Quy S; Le-Thi-Minh H; Nguyen-Thi-Bich H; Pham-Thu H; Thom VT; Pham-Thi-Hong N; Duong-Thi-Ly H; Nguyen-Huy B; Ngo-Minh X; Nguyen-Thi-Dieu T; Craig TJ
    J Breath Res; 2020 Nov; 15(1):016012. PubMed ID: 33108776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma, inhaled corticosteroid use, and bone mass in prepubertal children.
    Jones G; Ponsonby AL; Smith BJ; Carmichael A
    J Asthma; 2000; 37(7):603-11. PubMed ID: 11059528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.
    Calhoun WJ; Ameredes BT; King TS; Icitovic N; Bleecker ER; Castro M; Cherniack RM; Chinchilli VM; Craig T; Denlinger L; DiMango EA; Engle LL; Fahy JV; Grant JA; Israel E; Jarjour N; Kazani SD; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Moore WC; Pascual R; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Wasserman SI; Walter MJ; Wechsler ME; Boushey HA;
    JAMA; 2012 Sep; 308(10):987-97. PubMed ID: 22968888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial.
    McIvor RA; Kaplan A; Koch C; Sampalis JS
    Can Respir J; 2009; 16 Suppl A(Suppl A):11A-21A. PubMed ID: 19557207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
    Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
    JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Vähätalo I; Ilmarinen P; Tuomisto LE; Niemelä O; Kankaanranta H
    Respir Med; 2018 Apr; 137():70-76. PubMed ID: 29605216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and medium-term effect of inhaled corticosteroids on exhaled breath biomarkers in severe asthma.
    Alahmadi FH; Wilkinson M; Keevil B; Niven R; Fowler SJ
    J Breath Res; 2022 Jul; 16(4):. PubMed ID: 35724643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of lung function trend and FeNO for difficult asthma in children.
    Agache I; Ciobanu C
    J Investig Allergol Clin Immunol; 2012; 22(6):419-26. PubMed ID: 23101186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Eosinophil Cationic Protein Is a Useful Marker for Assessing the Efficacy of Inhaled Corticosteroid Therapy in Children with Bronchial Asthma.
    Guo CL; Sun XM; Wang XW; Guo Q
    Tohoku J Exp Med; 2017 Aug; 242(4):263-271. PubMed ID: 28781336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study.
    Sportel ET; Oude Wolcherink MJ; van der Palen J; Lenferink A; Thio BJ; Movig KLL; Brusse-Keizer MGJ
    Trials; 2020 Sep; 21(1):801. PubMed ID: 32943094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial.
    Baxter-Jones AD; Helms PJ; Russell G; Grant A; Ross S; Cairns JA; Ritchie L; Taylor R; Reid DM; Osman LM; Robins S; Fletcher ME
    Health Technol Assess; 2000; 4(28):1-89. PubMed ID: 11074396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
    Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G
    Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.
    Alahmadi F; Peel A; Keevil B; Niven R; Fowler SJ
    Clin Exp Allergy; 2021 Jan; 51(1):49-62. PubMed ID: 33190234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.